Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Calorimetric analysis of the plasma proteome: identification of type 1 diabetes patients with early renal function decline.

Garbett NC, Merchant ML, Chaires JB, Klein JB.

Biochim Biophys Acta. 2013 Oct;1830(10):4675-80. doi: 10.1016/j.bbagen.2013.05.007. Epub 2013 May 10.

2.

Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring.

Garbett NC, Mekmaysy CS, Helm CW, Jenson AB, Chaires JB.

Exp Mol Pathol. 2009 Jun;86(3):186-91. doi: 10.1016/j.yexmp.2008.12.001. Epub 2008 Dec 16. Review.

PMID:
19146849
3.

Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.

Krolewski AS.

Diabetes Care. 2015 Jun;38(6):954-62. doi: 10.2337/dc15-0184. Review.

4.

Early nephropathy in type 1 diabetes: the importance of early renal function decline.

Perkins BA, Krolewski AS.

Curr Opin Nephrol Hypertens. 2009 May;18(3):233-40. doi: 10.1097/MNH.0b013e3283293db1. Review.

5.

Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.

Steinke JM, Mauer M; International Diabetic Nephropathy Study Group..

Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Review.

PMID:
18806710
6.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

7.

Calorimetric analysis of the plasma proteome.

Garbett NC, Miller JJ, Jenson AB, Chaires JB.

Semin Nephrol. 2007 Nov;27(6):621-6. Review.

8.
9.

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.

Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C.

Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Review.

10.

Morphologic features of declining renal function in type 1 diabetes.

Najafian B, Mauer M.

Semin Nephrol. 2012 Sep;32(5):415-22. doi: 10.1016/j.semnephrol.2012.07.003. Review.

11.

Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients.

Mauer M, Caramori ML, Fioretto P, Najafian B.

Nephrol Dial Transplant. 2015 Jun;30(6):918-23. doi: 10.1093/ndt/gfu279. Epub 2014 Sep 1. Review.

12.

Differential scanning calorimetry (DSC) of semicrystalline polymers.

Schick C.

Anal Bioanal Chem. 2009 Nov;395(6):1589-611. doi: 10.1007/s00216-009-3169-y. Review.

PMID:
19834693
13.

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.

Mogensen CE.

J Intern Med. 2003 Jul;254(1):45-66. Review.

14.

Microalbuminuria as a risk predictor in diabetes: the continuing saga.

Bakris GL, Molitch M.

Diabetes Care. 2014;37(3):867-75. doi: 10.2337/dc13-1870. Review.

PMID:
24558077
15.

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A.

Cochrane Database Syst Rev. 2014 Feb 14;(2):CD009122. doi: 10.1002/14651858.CD009122.pub2. Review.

PMID:
24526393
16.

Early signs of disease in type 1 diabetes.

Moulder R, Lahesmaa R.

Pediatr Diabetes. 2016 Jul;17 Suppl 22:43-8. doi: 10.1111/pedi.12329. Review.

PMID:
27411436
17.

Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation.

Speake C, Odegard JM.

Biomark Insights. 2015 Sep 29;10(Suppl 4):19-24. doi: 10.4137/BMI.S29697. eCollection 2015. Review.

Supplemental Content

Support Center